BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation
about
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2019
@uk
name
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@en
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@nl
type
label
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@en
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@nl
prefLabel
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@en
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@nl
P2093
P921
P356
P1476
BET Bromodomain Inhibitor iBET ...... tal Allergic Lung Inflammation
@en
P2093
Antoon J M van Oosterhout
Ashutosh Pandey
Batika M Rana
Bernhard Kerscher
David F Tough
Deepali Jhamb
Helen E Jolin
Jillian L Barlow
Mayuri Gogoi
Michelle A Bartholomew
P356
10.3389/FIMMU.2019.00678
P407
P577
2019-01-01T00:00:00Z